Cove Therapeutics, Inc.

Cove Therapeutics, Inc. develops biodegradable polymeric nanoparticles for non-lipid, non-viral delivery of genetic medicine. The company's platform technology aims to address limitations in delivery efficiency, safety, and manufacturing for genetic therapeutic applications.